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Abstract: Skin whitening products are commercially available for cosmetic purposes in 
order to obtain a lighter skin appearance. They are also utilized for clinical treatment of 
pigmentary disorders such as melasma or postinflammatory hyperpigmentation. Whitening 
agents act at various levels of melanin production in the skin. Many of them are known as 
competitive inhibitors of tyrosinase, the key enzyme in melanogenesis. Others inhibit the 
maturation of this enzyme or the transport of pigment granules (melanosomes) from 
melanocytes to surrounding keratinocytes. In this review we present an overview of 
(natural) whitening products that may decrease skin pigmentation by their interference with 
the pigmentary processes. 
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1. Introduction 
In the skin, melanocytes are situated on the basal layer which separates dermis and epidermis. One 
melanocyte is surrounded by approximately 36 keratinocytes. Together, they form the so-called 
epidermal melanin unit. The melanin produced and stored inside the melanocyte in the melanosomal 
compartment is transported via dendrites to the overlaying keratinocytes. The melanin pigment is a 
polymer produced inside the melanosomes and synthesised from the amino acid L-tyrosine that is 
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converted by the enzyme tyrosinase to dopaquinone [1]. This reaction continues spontaneously via 
dopachrome to the monomeric indolic precursors (5,6-dihydroxyindole and 5,6-dihydroxyindole 
2-carboxylic acid) of the black-brown pigment eumelanin. However, some other enzymes, like the 
tyrosinase related proteins (TRP-1 and dopachrome tautomerase (TRP-2) may also play an important 
role in melanogenesis in vivo. Upon reaction with cysteine, dopaquinone forms 2- or 5-S-cysteinyldopa 
that generates the benzothiazine precursors of the red/yellow pheomelanin polymer. In general, a 
mixed type of pheo- and eumelanin polymer is produced and deposited onto the melanosomal matrix 
proteins. Considering the many colour variations that can be seen in the skin and hair, one may expect 
that the composition of the mixed melanins is regulated in many different ways. However, altered 
production of cutaneous melanin may cause considerable problems of esthetic nature, especially in 
hyperpigmentary conditions, like melasma, postinflammatory hyperpigmentation, freckles or 
lentigines. But also depigmenting conditions, like vitiligo, have high impact on the quality of life of 
the patients.  
In the Western culture it is still considered desirable to obtain a (bronze) tan. Despite warnings 
about the consequences of excessive sun or UV exposure, the artificial tanning business has expanded 
strongly in the last decades. In the Eastern world, however, a centuries long tradition exists whereby a 
light complexion is regarded as equivalent to youth and beauty. Development of preparations for 
bleaching hyperpigmented lesions or to safely achieve overall whitening is one of the challenges for 
cosmetic industry. In recent years, the interest in skin whitening has grown tremendously.  
2. Targeting Tyrosinase as the Key Enzyme of Melanogenesis 
One of the most obvious cellular targets for depigmenting agents is the enzyme tyrosinase. The 
scientific literature on tyrosinase inhibition shows that a large majority of the work has been conducted 
since 2000 and has mostly been devoted to the search for new depigmenting agents. Notably, many of 
these studies deal with tyrosinase inhibitors from natural sources and are mostly of Asian origin (see 
Tables 1 and 2). However, early pioneering work in the field has been performed much earlier using 4-
hydroxyanisole. This compound could serve as an alternative substrate for tyrosinase causing 
depigmentation both in vivo and in vitro [2,3]. Since this and various other substituted phenolic 
compound can generate potentially toxic quinone products they were used in various studies aimed at 
the induction of toxicity mediated by tyrosinase in melanoma cells [4,5]. 
Considerable interest in tyrosinase inhibitors exists also in the food industry because the activity of 
this enzyme is responsible for the browning of fruit and vegetables. Cysteine or ascorbic acid can be 
used to prevent the enzymatic browning of fruit and vegetables by binding the o-dopaquinone 
intermediates. More recently also 4-hexylresorcinol has been utilized for this purpose [6–9]. Since 
safety considerations are very strict in food industry, the search for new, natural tyrosinase inhibitors 
without negative side effects is of utmost importance in this field of research.  
Work on synthetic and natural tyrosinase inhibitors has been recently reviewed in several 
papers [7,9,10]. The tyrosinase inhibitors can be classified as competitive, uncompetitive, mixed type 
and non-competitive inhibitors [10]. The nature of tyrosinase inhibition can be disclosed by measuring 
enzyme inhibition kinetics using Lineweaver-Burk plots with varying concentrations of L-DOPA as 
the substrate. This can be seen on example of polyphenol extracts from acerola (West Indian cherry) or 
a chalcone derivative isolated from Morus nigra (black mulberry) which has been described in recent Int. J. Mol. Sci. 2009, 10                 
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work of Hanamura et al. and Zhang et al. [11,12]. Knowledge of the type of inhibition may be 
important in order to achieve better skin lightening effects since combined treatments may result in 
synergistic effects. This has been shown in case of the competitive tyrosinase inhibitor, arbutin and the 
noncompetitive inhibitor, aloesin [9,13].  
A 2009 paper by Chang states that a large majority of tyrosinase inhibitors show reversible 
inhibition [10]. In irreversible inhibition, covalent binding with the enzyme may cause its inactivation 
by altering the active site of the enzyme and/or by conformational changes to the protein molecule. 
Irreversible inhibition may also occur via the so-called suicide inhibition mechanism as described in 
the model by Land et al. [14]. Also, two 8-hydroxy isoflavones isolated from soygerm koji showed  
suicide inhibition of tyrosinase and have been tested with promising results in an in vivo assay with  
60 volunteers [10]. In Table 1 we summarize the large number of studies using tyrosinase inhibitors 
from natural sources that have appeared, mostly in the last decade. In many of the investigations, the 
active ingredients from extracts of various species have been isolated and identified. In case the mode 
of tyrosinase inhibition was established, a comparison with IC50 values of well known inhibitors such 
as kojic acid and arbutin was often made. In some of the studies specific side groups (with 
substitutions to C4, C5 or C8 position) of recorcinols isolated from the breadfruit (Artocarpus incisus) 
or from a ‘bitter root’ (Sophora flavescens) proved of great importance to their inhibitory potential 
[15,16]. In some cases modifications to the natural compounds were made, e.g., the deglycosylation of 
stilbene compounds by cellulase treatment of the Veratrum patulum extract resulted in improved 
tyrosinase inhibition [17]. Thus, exact knowledge on enzyme inhibition mechanisms is helpful for 
designing new whitening products based on targeting the key enzyme of melanogenesis, tyrosinase. 
Although tyrosinase plays a major role in melanin synthesis, one should realize that the regulation of 
skin pigmentation exists at various levels and therefore, different modes of interference are possible. 
There are indications that combined approaches could be more successful than targeting tyrosinase 
only.  
Table 1. Compounds selected as tyrosinase inhibitors by extraction from natural sources 
and the (possible) isolation and characterization of the active ingredients.  
Source Compounds  (type) 
Mode of action tested* 
TI               comments 
Refs. 
Chouji and Yakuchi 
extracts, crude drugs 
eugenol, yakuchinone A, ferulic acid, 
curcumin and yakuchinone B 
TI (c)    [18] 
Anacardium occidentale, 
cashew fruit 
6-[8(Z),11(Z),14-pentadecatrienyl]-
salicylic acid and 5-[8(Z),11(Z),14-
pentadecatrienyl]resorcinol 
TI (c)    [19] 
Bolivian medicinal 
plants, Buddleia 
coriacea, Gnaphalium 
cheiranthifolium, and 
Scheelea princeps. 
phenolic   TI    [20] 
Artocarpus gomezianus.  among eight other compounds 
norartocarpetin (5) and resveratrol 
(8) were isolated  
5,8 were 
most 
potent TI 
 [21] 
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Table 1. Cont. 
Source Compounds  (type) 
Mode of action tested* 
TI                    comments 
Refs. 
Artocarpus incisus  flavonoids, stilbenes and related 4-
substituted resorcinols 
TI   4-substituted 
recorcinol  
increases TI 
(c)  
[15] 
Stryphnodendron 
barbatimao, Portulaca 
pilosa, Cariniana 
brasiliensis, Entada 
africana and Prosopis 
africana. Five plants out of 
67 tropical plants 
unknown  strong TI  TI comparable 
to Morus alba 
as positive 
control 
[22]  
Pulsatilla cernua  3,4-dihydroxycinnamic acid (1) 4-
hydroxy-3-methoxycinnamic acid (2) 
2 > other TI 
> 1 
1,2 (nc) 
 [23] 
galls of Rhus javanica Tannic  acid  TI  -  [24] 
Sophora flavescens  prenylated flavonoids; kuraridin, 
kurarinone and norkurarinol 
strong TI > 
KA 
C8 and C5 
substitutionis 
essential for 
TI 
[16] 
 
Sophora flavescens  sophoraflavanone G, kuraridin, and 
kurarinone 
TI > KA    [25] 
Veratrum patulum   hydroxystilbene compounds; 
resveratrol, oxyresveratrol, and their 
analogs 
potent TI  cellulase 
treatment 
improved TI 
[17] 
Phellinus linteus  cerebroside B (1), protocate-
chualdehyde (2), 5-hydroxymethyl-2-
furaldehyde (HMF) (3), succinic acid 
(4), fumaric acid (5) 
2,3 TI 
2 > 3 
2 (c) 
3 (nc) 
 [26] 
Ecklonia stolonifera. 
edible brown alga out of 17 
seaweed extracts 
phloroglucinol derivatives 
[phloroglucinol (1), eckstolonol (2), 
eckol (3), phlorofucofuroeckol A (4), 
and dieckol (5)]. 
1,2 TI (c) 
3-5 (nc) 
TI similar to 
arbutin 
[27] 
39 seashore plant species, 
Japan: Hibiscus tiliaceus, 
Carex pumila, and 
Garcinia subelliptica  
GS contained 2 biflavonoids; 2R,3S-
5,7,4',5'',7'',3''',4'''-heptahydroxy- 
flavanone[3-8''] flavone (1) and 
5,7,4',5'',7'',3''',4'''-heptahydroxy[3-8''] 
biflavanone (2) 
both strong 
TI 
1 > KA 
 [28] 
Glycyrrhiza uralensis 
Glycyrrhiza inflate 
Licorice 
liquiritin(1), licuraside (2), 
isoliquiritin(3), liquiritigenin(4) and 
licochalcone A (5)  
2,3 and 5 
potent TI (c)  
 [29] 
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Table 1. Cont. 
Source Compounds  (type) 
Mode of action tested* 
TI                   comments 
Refs. 
Trifolium balansae  three steroids, stigmast-5-ene-3 
beta,26-diol (2), stigmast-5-ene-3-ol 
(3) and campesterol (4) 
2,3 and 4 
potent TI 
2 > 3,4 
 [30] 
Amberboa ramosa Jafri  cycloartane type triterpenoids; eight 
compounds identified. 3β,21,22,23-
tetrahydroxycycloart-24 (31),25(26)-
diene (cmpd. 7) 
7 most 
potent TI 
> KA 
SAR studies  [31] 
Sake lees  triacylglycerols; triolein (1) and 
trilinolein (2) 
TI 1,2 (nc) 
TI 2 > 1 
PI in E coli (2) [32] 
Garcinia kola  screening 21 families of medicinal 
plants from West and Central Africa. 
5 extracts selected with G. kola 
showing good TI; five biflavanones 
identified 
TI > 60%  
IC50 > KA 
 [33] 
Marrubium velutinum and 
Marrubium cylleneum 
Screening of 45 metabolites. 
Flavonoids (1), phenylethanoid 
glycosides (2), phenolic acids (3) 
1,2 
moderate 
TI, 3 < 2 
 [34] 
Lichen species; 
Graphidaceae family(1) 
Usnea ghattensis (2), 
Heterodermia podocarpa, 
Arthothelium awasthii (3) 
and Parmotrema tinctorum 
unknown TI  (1) 
30-78% 
 
 
antioxidant, 
antimicrobial, 
antityrosinase 
IC50 (2,3) 
similar or less 
than other TIs 
[35,36] 
Sophora flavescens  sophoraflavanone G (1), kurarinone 
(2) and kurarinol (3) 
strong TI 
1,2 (nc) 
3 (c) 
1,2 
antibacterial 
3 PI in SB 
MMS on 3 
[37] 
50 crude drugs 
Glycyrrhiza glabra, Morus 
alba, Syzygium 
aromaticum, Citrus au-
rantifolia, Cypreae mo-
neta, Punica granatum and 
Citrus aurantium 
 yes   
All < KA 
 [38] 
Ganoderma lucidum   yes    [39] 
Arbutus andrachne  Arbutin, hydroquinone, β-sitosterol 
and ursolic acid present in extracts 
yes   [40] 
Morus alba L. and Morus 
rotundiloba Koidz  
Mulberry  
betulinic acid (present)  yes  anti 
inflammatory 
[41] 
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Table 1. Cont. 
Source  Compounds (type)  Mode of action tested* 
TI                   comments 
Refs. 
Guioa villosa  sesquiterpene diglycosides; 
crenulatosides E, F and G ( 1 - 3) 
betulin ( 14), lupeol ( 15) and 
soyacerebroside I ( 16) 
 
no 
strong TI 
 [42] 
Broussonetia kazinoki.  1,3-diphenylpropanes: kazinol C (1), 
D (2), F (3), broussonin C (4), kazinol 
S (5) and kazinol T (6) 
1,3-5 (c)  
4; max TI  
- 
- 
[43] 
Artocarpus heterophyllus  15 compounds.  
norartocarpetin (4) and artocarpesin 
(6) 
yes  
5 cmpds > 
KA 
- 
- 
[44,45] 
Paeonia suffruticosa  kaempferol (I), quercetin (II), 
mudanpioside B (III), benzoyl-
oxypaeoniflorin (IV), mudanpioside 
H (V), and pentagalloyl-β-D-glucose 
(VI) 
yes  
I to V (c) 
VI (nc) 
- 
- 
[46] 
 
TI; tyrosinase inhibition, (c) competitive mode (nc) non competitive mode of inhibition. SB; 
Streptomyces bikiniensis [47]. MMS; molecular modeling studies on TI. SAR; structure activity 
relationship. PI; pigment inhibition.  
Tyrosinase inhibition among different studies is difficult to compare for several reasons (see also 
Chang [10]) because of different sources of tyrosinase used (see Parvez, [9]) and IC50 values that are 
found using either tyrosinase or L-DOPA as the substrate. In the table comparison to kojic acid (KA) 
for some of the component (number) is indicated as < or > or compounds are compared among each 
other (1 > 2).  
Extraction procedures for isolation and identification are highly important for good yield of the 
active ingredients. Many of the papers in Table 1 describe different extraction procedures. An 
overview of TI from natural and synthetic sources has been presented earlier in the review by Kim and 
Ujama [7].  
3. Different Modes of Reducing Melanin Production in Melanocytes and Skin 
As proposed by Briganti et al. all depigmenting agents may be divided on the basis of interference 
in melanin synthesis, transport and removal by skin turnover [48]. In Table 2, we sum up a large 
number of studies that describe new whitening agents from natural sources with some extra 
information on their mode of action besides the inhibition of tyrosinase. Next to tyrosinase inhibition 
(TI) the extracts or their isolated active components were demonstrated to exhibit pigment inhibition 
(PI). For this purpose, some studies make use of the pigment-producing S. bikiniensis (SB) system 
[37,49] or transformed E.coli [32]. In most cases, however B16 melanoma cells are used for 
demonstrating PI. In addition, PI is demonstrated in the mouse melan-a or mel-ab melanocyte cultures 
or in normal human melanocytes (nHEM). Obviously, the use of the nHEM may better simulate the in 
vivo situation. On the other hand, the melanocytes are more difficult to maintain in culture. These cells, Int. J. Mol. Sci. 2009, 10                 
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also show variations in melanin content from donor to donor and from one passage to the other [50]. 
Cocultures of melanocytes and keratinocytes from mouse [51,52] or human skin [53] more closely 
mimic the in vivo situation and, eventually, a skin equivalent model (SEM) may be the preferred in 
vitro system for testing skin whitening agents [54]. In this respect, recently commercially available 
SEM have already been applied for skin whitening studies [55]. Next to this, the brownish guinea pig 
(GP) model is used in several studies (Table 2) where the pigmentation is induced by either UV or α-
MSH. In case of in vivo studies, prevention of the induction of pigment by the whitening agents could 
be demonstrated using a Minolta chromameter or by histochemical investigations showing a decrease 
in DOPA positive cells [56,57]. Another animal model used for whitening studies is the zebrafish that 
also proved useful for demonstrating the in vivo toxicity of the whitening agents [58,59]. So far, only 
limited numbers of clinical trials (CT) with skin whitening agents or formulations have been 
performed [10,60]. 
Preventing the maturation or intracellular trafficking of tyrosinase is an alternative way to reduce 
the effect of the enzyme on pigmentation [61–63]. Various natural extracts can also influence 
tyrosinase mRNA at the transcription level; also mRNA of the other tyrosinase-related proteins or 
microphtalmia transcription factor (MITF) can be affected (see refs. [59,64,65] and others in Table 2). 
From the work of Sharlow et al. [66] and Seiberg [67] we learned that the protease activated receptor 2 
(PAR-2) is important for melanosomal transfer from melanocytes to keratinocytes and that this transfer 
can be used as a target for skin lightening [68]. The vitamin B3 derivative niacinamide is one of the 
agents used for inhibiting melanosomal transfer [53]. Melanocytes express high levels of sAPP, the 
soluble N-terminal ectodomain of the β-amyloid precursor protein [69]. sAPP may play a role in the 
release of melanin particles via dendritic tips. Blocking the sAPP signalling could thus be another way 
to influence melanosome transport.  
Mammone  et al. [70] (Estee Lauder) proposed that melanin can be degraded enzymatically in 
keratinocytes and application of melanin degrading enzymes could be used to prevent UVB induced 
pigmentation in human skin.  
Reduction of ROS levels in melanocytes may prevent activation of melanogenesis. In various 
studies, extracts from plants or fruit or other species were tested for their antioxidant capacity by using 
the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging assay or the oxygen radical absorbance 
capacity (ORAC) (e.g., Rangkadilok et al. [71]). Fujiwara and colleagues [72] showed that daily oral 
administration of vitamin C (ascorbic acid) and vitamin E and cysteine to brownish guinea pigs 
reduced UVB-induced pigmentation. Ascorbic acid is considered a skin whitening agent and more 
stable derivatives such as ascorbyl glucoside and ascorbyl palmitate are already being used in different 
skin whitening formulations [73]. As known from many cases of post-inflammatory 
hyperpigmentation, melanogenesis can be stimulated by some inflammatory mediators. Inhibition of 
the production of inflammatory mediators (Il1α and TNF-α) was reported for sea grape extracts [74]. 
Via this indirect way stimulation of melanogenesis in the pigment cells could be prevented [48].  Int. J. Mol. Sci. 2009, 10                 
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Table 2. New whitening agents from natural sources and their mode of action as tyrosinase 
inhibitor (TI), inhibitor of pigment synthesis (PI) or by other mechanisms. Azelaic acid, 
Kojic acid, Arbutin and Aloesin are often used as positive skin whitening agents. 
Source Compounds  (type) 
Mode of action tested(*)(**) 
Refs. 
TI PI other 
Pityrosporum 
ovale 
Azelaic acid; C9-
dicarboxylic acid 
yes yes -  [75]   
Aspergillus niger 
and Aspergillus 
penicillium 
Kojic acid; 5-hydroxy-2-
(hydroxymethyl)-γ-pyrone 
Yes (c,m)  -  -  [76,77] 
Arctostaphylos 
uva-ursi 
bearberry 
Arbutin; hydroquinone 
glucoside β-d-
gluconopyranoside 
yes 
(c,m,nc) 
- -  [13,78] 
[79]  
Aloe vera  Aloesin; C-glycosylated 
chromone 
yes (nc)  -  -  [9,13,80]
Artocarpus incisus 
(best of) 
23 heart wood 
species from Papua 
New Guinea.  
(+)-dihydromorin, 
chlorophorin, (+)-
norartocarpanone, 4-prenyl-
oxyresveratrol, artocarbene, 
artocarpesin and isoarto-
carpesin 
yes≈ KA 
 
yes  
(B16 and 
GP) 
- [81] 
Morus alba 
Rheum undulatum 
1. Oxyresveratrol  
 
2. Hydroxystilbene  
yes > KA 
(nc) 
yes 
-  1. no effect on 
expression or 
synthesis 
[82] 
Morus alba  Mulberroside F (moracin M-
6, 3'-di-O-beta-D-
glucopyranoside 
yes yes   
(melan-a) 
mild anti-
oxidant SO 
scavenger <KA 
[83] 
Citrus fruit peel  3',4',5,6,7,8-hexamethoxy-
flavone (nobiletin) 
yes > KA    antimutagenic  [84] 
Ramulus mori 
(young twigs of 
Morus alba)  
2,3',4,5'-tetrahydroxy-
stilbene (2-oxyresveratrol) 
yes (c)  yes  
(GP + UV) 
no effect on 
expression or 
synthesis 
non-toxic 
[85] 
Glycyrrhiza glabra 
Licorice extract 
glabrene and 2',4',4-tri-
hydroxychalcone 
yes yes   [86] 
Grape seed   proanthocyanidin  yes  yes  
(B16,  
GP + UV) 
antioxidant 
activity, 
8OHdG 
[56] 
Aspergillus 
fumigatus and 
Saccharomyces 
cerevisiae 
melanin degrading enzymes  -  -    [70] 
Carthamus 
tinctorius 
safflower seeds 
1) N-feruloylserotonin,2) N-
(p-coumaroyl)serotonin, and 
3) acacetin 
yes, 1,2 > 
arbutin 
yes  
(SB, B16). 
1,2 > 
arbutin 
 [49] Int. J. Mol. Sci. 2009, 10                 
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Table 2. Cont. 
Source Compounds  (type) 
Mode of action tested(*)(**) 
Refs. 
TI PI other 
Glycyrrhiza 
uralensis 
Glycyrrhisoflavone (1) and 
glyasperin C(2) 
yes yes   
(B16) 1 > 2 
 [87] 
Punica granatum 
Pomegranate  
ellagic acid  yes ≈ Arb  yes (GP + 
UV) ≈ AA 
 [57] 
Fish, Poultry  vitamin B3 derivative, 
niacinamide 
no no 
 
MT inh.  
Mc/Kc cocult. 
CT 
 
[53] 
Piper longum  piperlonguminine no  yes 
(B16 + 
msh) 
Tyr mRNA red. 
cAMP pathway 
via MITF inh. 
[88,89] 
 
Angelica dahurica  isoimperatorin 
imperatorin 
no yes 
(B16) 
Tyr protein + 
mRNA red. 
[90]  
Artocarpus 
lakoocha 
heartwood  
oxyresveratrol yes  Nd  CT  (female 
volunteers) > 
KA > licorice  
[60] 
Astragalus 
taschkendicus 
askendoside B  yes  Nd    [91] 
Spatholobus 
suberectus Dunn 
(Leguminosae) 
Chinese herb 
Butin (most effective 
compound) 
yes yes   
(nHEM) 
Tyr,Trp-1 and 
Trp-2 reduced 
(WB,qPCR) 
[64] 
Sophora japonica 
and Spatholobus 
suberectus out of 
25 Chinese Herbs 
high phenolic content, e.g., 
gallic acid 
yes yes   
(nHEM) 
AO activity 
(DPPH) 
[92]  
Galla Chinensis 
Radix Clematidis 
out of 90 Chinese 
Herbs 
unknown yes  yes   
(Mel-ab, 
melan-a, 
melan-a/ 
SP1 
cocult.)  
Effects on Tyr, 
Trp-1 and Trp-2 
expression 
[52] 
Kaempferia 
pandurata 
chalcone compounds, 
isopanduratin A and 4-
hydroxypanduratin A 
yes > PTU  yes  
(melan-a) > 
PTU 
Tyr protein 
reduced 
[93] 
Corn bran  Polyamine conjugates, N,N'-
dicoumaroylputrescine 
(DCP), N-p-coumaroyl-N'-
feruloylputrescine (CFP), 
and N,N'-diferuloyl-
putrescine (DFP) 
yes 
DCP > AA 
yes  
(B16) 
DFP > Arb 
AO activity 
(DPPH) 
 
[94] Int. J. Mol. Sci. 2009, 10                 
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Table 2. Cont. 
Source Compounds  (type) 
Mode of action tested(*)(**)  
Refs. 
TI PI TI 
Podocarpus 
macrophyllus 
2,3-dihydro-4',4'''-di-O-
methylamentoflavone 
yes yes   
(nHEM) 
Trp-2 mRNA 
reduced 
[95] 
Longan seed   corilagin, gallic acid and 
ellagic acid or other 
phenolic/flavonoid 
glycosides and ellagitannins 
yes n.d. AO  activity 
(DPPH and 
ORAC assays) 
[71] 
Gastrodia elata 
Blume 
Orchidaceae  
(synthetic) p-hydroxybenzyl 
alcohol 
yes (Irrev)  yes  
(B16, 
mouse MC-
KC cocult.) 
AO; radical 
scavenger 
[51,96] 
Sophora flavescens  1) kurarinol, 2) kuraridinol, 
and 3) trifolirhizin 
yes 
1,2 > KA 
1,2 (nc) 
yes (B16)    [97] 
Cucumis sativus  Lutein no  yes  (B16)  Tyr  protein 
reduced 
[98] 
Lespedeza 
cyrtobotrya 
Haginin A  yes (nc)  yes  
(melan-a) 
GP (+UV) 
zebra fish 
MITF, Tyr, 
Trp-1 reduced. 
Erk induced 
[59]  
Malpighia 
emarginata 
Acerola fruit 
cyanidin-3-alpha-O-
rhamnoside. pelargonidin-3-
α-O-rhamnoside 
yes yes  (B16) 
GP (+UV) 
 [11] 
Coccoloba uvifera  
Sea grape 
unknown yes 
(nHEM) 
 AO;  reduces 
IL-1alpha, 
TNF-alpha and 
alpha-MSH in 
nHEM + UV 
[74] 
Salicornia 
herbacea, 
halophyte  
  yes  yes (B16)  AO activity  [99] 
Allium species 
such as garlic and 
onions. 
1-propylmercaptan yes≈ KA 
 
yes ≈ KA 
 
 [100] 
Willughbeia 
coriacea 
Phyllanthus 
urinaria out of 14 
medicinal plants 
Central 
Kalimantan 
unknown yes 
 
yes 
yes (B16) 
 
yes (B16) 
AO assay 
DPPH 
 
[101] Int. J. Mol. Sci. 2009, 10                 
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Table 2. Cont. 
Source Compounds  (type) 
Mode of action tested(*)(**) 
Refs. 
TI PI  other 
Rhus Ghinensis; 
Chinese galls 
3 Gallotannins; 2,3,4,6-tetra-
O-galloyl-D-glucopyranose, 
1,2,3,6-tetra-O-galloyl-β-D-
glucopyranose, and 1,2,3,4,6-
penta-O-galloyl-β-D-
glucopyranose 
yes (nc)  Yes 
(B16 + UVA; 
MSH) 
 [102] 
Rhus succedanea  10'(Z)-heptadecenyl-
hydroquinone 
yes > HQ  yes > HQ 
(B16)  
 [103] 
Polygonum 
cuspidatum.  
Paris polyphylla  
Vitex negundo 
Physcion (anthraquinone + 
anthraquinone analog) 
 
(+)-Lyoniresinol 
yes ≈ KA 
yes > KA 
 
yes > KA 
n.d. 
n.d. 
 
n.d, 
Good skin 
permeation 
[10,104] 
 
[105] 
Raspberry Tiliroside  yes  Yes  (B16)  >Arb  [106] 
Erigeron 
breviscapus 
Chinese herb 
(2Z,8Z)-matricaria acid 
methyl ester 
no   yes (B16, elan-
a > Arb 
Tyr protein 
reduced? 
[107] 
Alpinia galanga 
and Curcuma 
aromatica 
medicinal plants 
eugenol and curcuminoids 
possible active ingredients 
yes  yes (G361 ma 
cells + UVA) 
AO defence  [108] 
Grape seed  oligomeric 
proanthocyanidins 
-  yes, nHEM + 
UV 
effects on 
TE, Trp-1 
and Trp-2 
expression 
AO activity 
[65] 
* Modes of action tested; TI; tyrosinase inhibition, (c)competitive (u) uncompetitive (nc) non-
competitive and (m) mixed mode; PI; pigment inhibition, SB; Streptomyces bikiniensis, B16 or 
other melanoma cultures, melan-a mouse melanocytes, nHEM; normal human epidermal 
melanocytes, SEM; skin equivalent model, (α)-msh; (α)-melanocyte stimulating hormone, UV; 
ultraviolet, GP; guinea pig + msh or uv induced pigmentation; CT; tested in clinical trial.   
** Comparison of effects on tyrosinase inhibition (TI) and pigmentation inhibition (PI) are mostly 
done in comparison to Arbutin (Arb), Kojic acid (KA) Ascorbic Acid (AA) and phenylthiourea 
(PTU). Other modes of action; AO; antioxidant; TE; tyrosinase expression (mRNA), MT; 
melanosome transport; 8OHdg = 8 hydroxy deoxy guanosine. 
4. Induction of Pigmentation 
For the development of effective skin whitening, we also need to understand processes that regulate 
the induction of pigmentation. Constitutive pigmentation is reflected by the phenotypes of the different 
skin types with varying pigmentation based on their genetic diversity. The facultative pigmentation 
acquired on top of the constitutive level can be obtained via different stimuli of which ultraviolet 
radiation (UVR) is well known as provoking the “tanning response”. An overview of the signalling 
pathways and intrinsic and extrinsic factors (inclusive UV) that influence melanocyte proliferation or Int. J. Mol. Sci. 2009, 10                 
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metabolism can be found in the paper by Brenner and Hearing [109]. In brief, the UV response 
increases the microphtalmia-associated transcription factor (MITF) that is on its turn regulated by 
another transcription factor SOX9 [110]. MI is the main switch for induction of the melanogenic 
proteins responsible for the final increase of the melanin content in skin after UV exposure. Various 
pathways can be induced by the signalling through basic fibroblast growth factor (bFGF), hepatocyte 
growth factor (HGF), stem cell factor (SCF), endothelin-1 (ET-1), adrenocorticotropic hormone and α-
melanocyte stimulating hormone (ACTH and α-MSH) via their respective receptors present on 
melanocytes and thus stimulating their pigment production. These signalling pathways could also 
serve as a means of specific targeting the melanogenic pathway. In this way, the presence of 
melanocortin-1 receptor (MC1R) on (B16) melanoma cells has been often used for induction of 
pigmentation and for testing the depigmenting effects of natural skin lighteners (see examples in   
Table 2).  
Several authors focus on factors that were not directly involved in melanin synthesis but could 
affect proteins indirectly connected with skin pigmentation. For instance, the endothelin-1 induction of 
pigmentation in melanocytes could be prevented by 3’antisense S-oligo for tyrosinase that also 
reduced UV induced pigmentation [111].  
The Wnt/β-catenin pathway is known to play an important role in developmental processes [112]. 
Binding of Wnt proteins to their receptors (the frizzled family of transmembrane proteins)can be 
inhibited by Dikkopf 1 (DKK1), a factor secreted by fibroblasts which can suppress growth of 
melanocytes and strongly inhibit melanin production [109,113]. Thus, some of the natural whitening 
agents presented in Table 1 or 2 are not direct inhibitors of tyrosinase but downregulate expression of 
melanogenic proteins and in this way they may interfere with the complex regulation of melanocyte 
signalling cascades. Stem cell factor is a cytokine that binds to the c-kit receptor (CD117) and the 
activation of c-Kit leads to the activation of multiple signaling cascades, including the RAS/ERK, PI3-
Kinase, Src kinase, and JAK/STAT pathways [114]. Na and coworkers [115] have used the signalling 
via SCF/c-kit for the evaluation of new whitening agents by high throughput screening with 
approximately 10.000 synthetic compounds. They found that phenyl-imidazole sulfonamide 
derivatives prevented stem cell factor induced c-kit phosphorylation in (501mel) human melanoma 
cells and also the UV induced pigmentation on brownish guinea pigs. Furthermore, the SCF/c-kit 
pathway was used to induce pigmentation in case of vitiligo. Geniposide (from the fruit of Gardenia 
jasminoides Ellis) is used in traditional Chinese medicine for treatment of generalized vitiligo. This 
compound was shown to increase pigmentation via SCF/c-kit in normal human melanocytes where 
melanogenesis was suppressed by norepinephrine [116]. In the case of SOX9 and MITF, signalling is 
mediated via cAMP and PKA [110], but also the stimulation of PKC (via diacylglycerol and calcium) 
may results in activation of tyrosinase. Inhibition of PKC by the specific PKC inhibitor 
bisindolylmaleimide (bis) resulted in a reduced tanning response in pigmented guinea pigs and in a 
marked lightening of freshly depilated hairs in mice [117].  
Furthermore, Yaar et al. [118] proposed bone morphogenetic proteins (BMPs) to be involved in 
modulating melanogenesis since melanocytes express the BMP receptors and produce BMP-4, that is 
able to decrease melanin synthesis in human melanocytes in culture. Another mechanism of pigment 
regulation is suggested for the peroxisome proliferator- activated receptor (PPAR) since binding of Int. J. Mol. Sci. 2009, 10                 
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octadecenedioic acid to this PPAR leads to reduced melanogenesis and tyrosinase expression. The 
same was found for a known pharmaceutical PPAR agonist rosiglitazone [119].  
Another pathway indicated in several papers by Kim et al. is the signalling via extracellular signal-
regulated kinases (ERK). This pathway can be triggered by different stimuli, like growth factors 
(bFGF and HGF) and cytokines (SCF), as indicated above. The authors first reported that c2-ceramide 
inhibits melanogenesis by activation of ERK and they showed that inhibition of ERK (and AKT/PKB) 
caused an increase in pigmentation in human melanocytes [120]. As a follow-up they described a new 
2-imino-1,3-thiazoline derivative that decreased melanin production in B16 melanoma cells via 
induction of ERK [121]. More recently they showed that terrein, which acted on ERK and 
downregulated MITF, in combination with a new tyrosinase inhibitor, KI-063, caused additive effects 
on depigmentation in the Mel-ab melanocytes [122]. They also described a new imidazole derivative 
AVS-1357 that reduced pigmentation by activation of ERK and the downregulation of MITF and 
tyrosinase [123]. Similar results were achieved with haginin A that inhibited tyrosinase and also 
activated ERK and thus downregulated MITF and tyrosinase and TRP-1. Haginin A effectively 
reduced pigmentation in the brownish guinea pig and the zebrafish model systems [59].  
The effects of ceramide on pigmentation is of interest as well since it has been reported that 
glycosylation of lipids could be of importance for proper sorting of the melanogenic proteins to the 
melanosomes [124]. A glycosphingolipid-deficient melanoma culture was not pigmented and by 
transfection with ceramide glucosyltransferase, pigmentation could be restored [124]. We found that 
reducing the levels of glucosylceramide may affect pigment production in normal human melanocytes. 
In this respect it is interesting to note that 1-deoxynojirimycin (DNJ) is a glycosidase inhibitor and one 
of the main components in mulberry leaves (from Morus alba) [125] and personal communication 
Aerts JMG, Academic Medical Center, University of Amsterdam). As shown in Tables 1 and 2 the 
compounds isolated from Morus alba (oxyresveratrol , mulberroside F and betulinic acid) inhibited 
tyrosinase [41,82,83] but the effect of DNJ on lipid glycosylation could inhibit melanin synthesis as 
well (N. Smit, manuscript in preparation).  
5. Cosmetic Use of (natural) Agents for Skin Whitening 
In cosmetic formulations hydroquinone (HQ) has been widely used as an effective whitening agent 
but it has been banned recently because of serious safety concerns: its use has been connected with 
mutagenicity and the increased incidence of ochronosis in African countries. Other compounds often 
used are kojic acid, arbutin and azelaic acid (see top of Table 2). Arbutin is a glycosylated form of HQ 
that is present in bearberry extracts but it can also be synthesized from HQ by glucosidation. A new 
derivative, deoxyarbutin was prepared by removal of all hydroxyl groups from the glucose side chain 
of arbutin and showed much lower cytotoxicity than arbutin [126,127]. In the large variety of 
whitening products, nowadays commercially available the use of different natural whitening agents is 
noticeable. Although the information on the exact formulations for all the whitening products is not 
easily accessible on the internet, we made an attempt to summarize the active whitening ingredients for 
some of them (Table 3). The utilization of kojic acid and arbutin is still common because these agents 
have repeatedly been demonstrated to be effective whitening agents. The use of bearberry extracts (a 
natural source of β-arbutin) may strengthen the effect of α-arbutin in Meladerm and Lucederm 
preparations. Among the natural extracts, mulberry and licorice are popular components added to the Int. J. Mol. Sci. 2009, 10                 
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skin whiteners. The isolation of their active components and their ffect on tyrosinase inhibition (TI) 
and pigment reduction (PI) has been described (see Tables 1 and 2). Also lemon extract is used in the 
preparations like Skin Bright, Lucederm and Meladerm as a potent skin bleaching ingredient. 
However, it can only be used at low concentrations because it easily causes skin irritation. In Tables 1 
and 2 several studies are included describing Sophora species from which several active compounds 
have been isolated that act as potent inhibitors of tyrosinase and pigment production. Also in the 
product Synerlight from LiBiol an extract from Sophora species is present. In this case it is combined 
with Kiwi fruit (Actinidia Chinensis) which contains flavonoids (e.g., quercetin) that may be 
responsible for tyrosinase inhibition [10]. Niacinamide, which besides inhibition of tyrosinase, 
interferes in melanosome transfer to keratinocytes is used in the formulations of Meladerm and 
Lucederm. The Revitol product Skin Brightener contains Lumiskin with some patented ingredient, 
diacetyl boldine, that influences tyrosinase at the expression level. The Mandresy extract of Bayer 
contains two compounds luteolin and verbascoside that do not only inhibit tyrosinase and pigment 
production but also influence the interaction between keratinocytes and melanocytes by reducing 
formation of dendrites. Some of the products (Meladerm and Tosseki whitening cream) contain a 
mixture of many extracts with the obvious tyrosinase inhibitors (Mulberry, Licorice, Sophora and 
Peonia) but also other extracts that may act as antioxidant or anti-inflammatory. One of the 
components of the Meladerm preparation is TegoCosmo which contains a guanidine compound that 
acts on tyrosinase activity. Another component is Gigawhite that contains various plant extracts from 
the Alps and that has been tested on 10 subjects of Asian origin. Its bleaching effects may partly be 
attributed to tyrosinase inhibition. The question arises whether the increasing amounts of potentially 
active whitening ingredients will cause additive effects or will reduce the effects of the most potent 
ingredients (by competitive inhibition).  
Some companies still use single synthetic compounds. For instance Lipotec uses dimetylmethoxy 
chromanyl palmitate in its product Chromabright. This exhibited lightening activity in a group of  
20 Asian volunteers after 30 and 60 days. Sederma company makes use of a new mechanism of action 
targeting the peroxisome proliferator- activated receptor (PPAR). Their active ingredient named 
O.D.A. White is able to reduce tyrosinase mRNA expression [119]. 
Thus, approaches for skin whitening have broadened widely in the recent years. The utilization of 
single agents inhibiting tyrosinase is in many cases extended to the use of complex mixtures that target 
different mechanism like tyrosinase expression, transfer of melanosomes, antioxidant and anti-
inflammatory effects. 
Table 3. Limited selection of whitening products available on the market with some 
information on active ingredients. 
Company Product  Ingredients  Documentation;  in Vitro/in Vivo Effect 
Revitol Skin  Brightener  Arbutin, Lumiskin (diacetyl boldine), 
Z Whitener (new natural ingredient, 
unknown) + vitamins A,C and E and 
other natural extracts (antioxidants)  
Lumiskin TM: action on tyrosinase 
expression based on principle described by 
Fuller 2000 [128] 
http://naturalskincareformula.com/ 
Premium 
Naturals  
Skinbright  Arbutin, Kojic Acid, Lemon Extract   www.whiterskin.com/ 
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Table 3. Cont. 
Company Product  Ingredients  Documentation;  in Vitro/in Vivo Effect 
Sisquoc Lucederm  Niacinamide,  α-Arbutin, Kojic Acid, 
Mulberry, Bearberry, Licorice, Lemon 
www.whiterskin.com/  
[29,53,82,83] 
LIBiol Synerlight  Actinidia Chinensis (Kiwi) Fruit, 
Sophora Angustifolia Root  
http://www.gattefossecanada.ca/ 
Bayer 
HealthCare 
Mandresy 
extract  
Buddleja axillaris leaves; extract rich 
in orthocinnamic compounds and 
flavonoids, verbascoside & luteolin  
TI (mushroom); PI (nHEM + UV); reduces 
dendricity; in vivo brightening 8 volunteers 
(Chromameter)  
www.serdex-plantextracts.com: United States 
Patent Application 20090028969 
Civant Skin 
care  
Meladerm Kojic  Acid,  α-Arbutin, Niacinamide, 
Mulberry, Bearberry, Licorice, Tego® 
Cosmo C250, Gigawhite, Lemon 
Juice, Emblica  
TegoCosmo; a natural amino acid 
derivative that belongs to the class of 
guanidine compounds 
 Giga white:plant extracts from the 
Swiss alps; Malva Sylvestris, Mentha 
Piperita, Primula Veris, Alchemilla 
Vulgaris, Veronica Officinalis, 
Melissa Officinalis, Achillea 
Millefolium 
niacinamide, mulberry and licorice (refs. 
[29,53,82,83])  
www.whiterskin.com/; 
http://www.whiterskin.com/studies/cosmo.pdf 
http://www.whiterskin.com/studies/giga.pdf 
Juju 
Cosmetics 
Tosekki 
whitening 
cream 
Glycyrrhetinic acid, Ginseng, 
Houttuynia, Yeast, Coix, Horse 
Chestnut, Arica, Grape Leaf, 
Ypericum, Ivy, Witch Hazel, Sophora 
Root, Mulberry Bark, Peony Root, 
Japanese Angelica Root, Rose Fruit 
and other ingredients. 
Glycyrrhetinc acid; Sophora Root; Peony 
Root; Mulberry Bark ( refs. 
[25,29,38,46,82,83,86])  
http://beautyknot.wordpress.com/2009/02/27/j
uju-cosmetics-tosekki-whitening-cream/ 
Lipotec  Chromabright  dimetylmethoxy chromanyl palmitate   TI (mushroom + human); PI (nHEM) 
photoprotective; in vivo brightening 20 Asian 
females (Chromameter) www.lipotec.com ; 
Patent; http://www.maxworth.co.th/max/pdf 
/ES291%20Chromabriht.pdf 
Abbreviations 
AA; Ascorbic Acid, ACTH; adrenocorticotropic hormone, AO; antioxidant, Arb; Arbutin, bFGF; 
basic fibroblast growth factor, BMP; bone morphogenetic proteins, cAMP; cyclic AMP, CT; clinical 
trials, DNJ; 1-deoxynojirimycin, DPPH; 1,1-diphenyl-2-picrylhydrazyl, ET-1; endothelin-1, ERK; 
extracellular signal-regulated kinases, GP; guinea pig, HGF; hepatocyte growth factor, HQ; 
hydroquinone, IC50; half maximal inhibitory concentration, Il1α; interleukin 1α, KA; kojic acid,   
L-DOPA;  L-dihydroxyphenylalanine, MC1R; melanocortin-1 receptor, MITF; microphtalmia 
transcription factor, (α)-msh; (α)-melanocyte stimulating hormone, MT; melanosome transport; Int. J. Mol. Sci. 2009, 10                 
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nHEM; normal human epidermal melanocytes, 8OHdg = 8 hydroxy deoxy guanosine, ORAC; oxygen 
radical absorbance capacity, PKA; protein kinase A, PKC; protein kinase C, PPAR; peroxisome 
proliferator- activated receptor, PTU; phenylthiourea, SAR; structure activity relationship, sAPP; 
soluble N-terminal ectodomain of the beta-amyloid precursor protein, SCF; stem cell factor, SEM; 
skin equivalent model, Sox; Sry-related HMG box, TE; tyrosinase expression, TI; tyrosinase 
inhibition, (c); competitive mode, (nc); non competitive mode, (m); mixed mode of inhibition, TNF-α; 
tumor necrosis factor-α, TRP; tyrosinase related protein, UV; ultraviolet, UVA; ultraviolet A, UVB; 
ultraviolet B, UVR; ultraviolet radiation. 
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